ALCOHOLIC HEPATITIS AND ITS ASSESSMENT USING THE GLASGOW ALCOHOLIC HEPATITIS SCORE
Keywords:
Alcoholic hepatitis, alcohol-related liver disease, hepatomegaly, jaundice, liver inflammation, Glasgow Alcoholic Hepatitis Score, prognosis, liver cirrhosis.Abstract
Alcoholic hepatitis is an inflammatory liver disease caused by excessive and prolonged alcohol consumption. It represents a significant health burden worldwide due to its association with liver failure, cirrhosis, and increased mortality. The pathophysiology of alcoholic hepatitis involves hepatocellular injury, oxidative stress, inflammatory cytokine release, and progressive fibrosis. Clinical manifestations range from mild symptoms to severe presentations, including jaundice, abdominal pain, hepatomegaly, ascites, and hepatic encephalopathy. Assessment of disease severity and prognosis is essential for patient management. The Glasgow Alcoholic Hepatitis Score (GAHS) is a useful tool for evaluating disease severity and predicting outcomes. Understanding the etiology, pathophysiology, clinical features, and prognostic factors of alcoholic hepatitis is important for early diagnosis and appropriate treatment, ultimately improving patient outcomes.
References
1. A. G. Gadayev Ichki kasalliklar propedevtikasi 2016
2. Im GY, Cameron AM, Lucey MR. Liver transplantation for alcoholic hepatitis. J Hepatol. 2019 Feb;70(2):328-334. [PubMed]
3. Gustot T, Jalan R. Acute-on-chronic liver failure in patients with alcohol-related liver disease. J Hepatol. 2019 Feb;70(2):319-327. [PubMed]
4. Mathurin P, Thursz M. Endpoints and patient stratification in clinical trials for alcoholic hepatitis. J Hepatol. 2019 Feb;70(2):314-318. [PubMed]
5. Singal AK, Shah VH. Current trials and novel therapeutic targets for alcoholic hepatitis. J Hepatol. 2019 Feb;70(2):305-313. [PubMed
6. Mohlaroyim: Gao B, Ahmad MF, Nagy LE, Tsukamoto H. Inflammatory pathways in alcoholic steatohepatitis. J Hepatol. 2019 Feb;70(2):249-259. [PMC free article] [PubMed]
7. Milosevic I, Vujovic A, Barac A, Djelic M, Korac M, Radovanovic Spurnic A, Gmizic I, Stevanovic O, Djordjevic V, Lekic N, Russo E, Amedei A. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature. Int J Mol Sci. 2019 Jan 17;20(2) [PMC free article] [PubMed]
8. García-Carretero R, Barquero-Pérez O, Mora-Jiménez I, Soguero-Ruiz C, Goya-Esteban R, Rodríguez-Castro C, Ramos-López J. [Prevalence and clinical features of non-alcoholic steatohepatitis in a hypertensive population]. Hipertens Riesgo Vasc. 2019 Jul-Sep;36(3):130-136. [PubMed]
9. Urban SK, Mocan T, Sänger H, Lukacs-Kornek V, Kornek M. Extracellular Vesicles in Liver Diseases: Diagnostic, Prognostic, and Therapeutic Application. Semin Liver Dis. 2019 Feb;39(1):70-77. [PubMed